Get the Stockscreener App
4.99
16.05%
0.69
After Hours:
4.86
-0.13
-2.61%
Endra Life Sciences Inc stock is traded at $4.99, with a volume of 158.54K.
It is up +16.05% in the last 24 hours and down -4.04% over the past month.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
See More
Previous Close:
$4.30
Open:
$4.47
24h Volume:
158.54K
Relative Volume:
4.84
Market Cap:
$9.22M
Revenue:
-
Net Income/Loss:
$-7.30M
P/E Ratio:
-0.6124
EPS:
-8.148
Net Cash Flow:
$-8.01M
1W Performance:
+4.83%
1M Performance:
-4.04%
6M Performance:
-1.77%
1Y Performance:
+42.57%
1-Day Range:
$4.47
$5.30
1-Week Range:
$3.60
$6.67
52-Week Range:
$2.96
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.99 | 7.95M | 0 | -7.30M | -8.01M | -8.148 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Endra Life Sciences Inc Stock (NDRA) Latest News
Price to earnings forward of ENDRA Life Sciences Inc. – NASDAQ:NDRA - TradingView
Enterprise value to revenue forward of ENDRA Life Sciences Inc. – NASDAQ:NDRA - TradingView
Strategic Merger Brings Rare Helium & LNG Platform to Global Investors as Renergen, ENDRA, and ASPI Unite - Minichart
ENDRA Life Sciences to Merge, Rebrand as Noble Africa - TipRanks
ENDRA (NDRA) to merge, raise ~$50M and rebrand as Noble Africa Inc. - Stock Titan
ENDRA (NASDAQ: NDRA) sets Noble Africa merger and $50M Noble investment - Stock Titan
Form 144 Endra Life Sciences Inc. For: 25 June By Investing.com - Investing.com Australia
ASP Isotopes to merge Noble Africa with a unit of ENDRA – a look at the key contours of the deal - MSN
[144] ENDRA Life Sciences Inc. SEC Filing - Stock Titan
ENDRA Life Sciences Inc. Actuals & Estimates (NASDAQ:NDRA) - TradingView
ASP Isotopes / ENDRA merger deal: $50M financing, governance split (NDRA) - Stock Titan
ENDRA Life Sciences Inc. Actuals & Estimates (BOATS:NDRA) - TradingView
NDRA Stock Alert: Halper Sadeh LLC is Investigating Whether ENDRA Life Sciences Inc. is Obtaining a Fair Price for its Shareholders - The Joplin Globe
ASP Isotopes To Merge Noble Africa With A Unit Of ENDRA – A Look At The Key Contours Of The Deal - Asianet Newsable
ASP Isotopes (ASPI) Forms Strategic Merger with ENDRA Life Scien - GuruFocus
NDRA Forecast — Price Target — Prediction for 2027 - TradingView
ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences - TradingView
ASP Isotopes announces proposed merger of Noble Africa, ENDRA Life Sciences - TipRanks
ASP Isotopes' Noble Africa to Merge With Endra - Moomoo
ASP Isotopes' Noble Africa unit to merge with ENDRA Life Sciences unit in $50M deal (ASPI:NASDAQ) - Seeking Alpha
ENDRA Life Sciences Plans Merger Creating Noble Africa Helium Platform - TipRanks
ASP Isotopes Plans Noble Africa Merger With ENDRA to Create Nasdaq-Listed Helium Company - citybiz
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing - Business Wire
ENDRA subsidiary to merge with Noble Africa; concurrent $50M private placement planned - TradingView
ENDRA Life Sciences (NDRA) proposes merger of subsidiary with Noble Africa - Stock Titan
ASP Isotopes backs $50M deal for a Nasdaq helium platform - Stock Titan
ASP Isotopes Inc. has announced a major strategic initiative, planning to advance a merger between its subsidiary Noble Africa and ENDRA Life Sciences Inc. - Bitget
ENDRA Life Sciences Inc (NDRA) Institutional Confidence - TradingKey
ENDRA Life Sciences Inc (NDRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
ENDRA Life Sciences Inc (NDRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ENDRA Life Sciences Inc (NDRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NDRA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ENDRA Life Sciences Inc (NDRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ENDRA Life Sciences Inc (NDRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ENDRA Life Sciences Inc (NDRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ENDRA Life Sciences Inc (NDRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ENDRA Life Sciences Inc (NDRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NDRA Technical Analysis & Stock Price Forecast - Intellectia AI
NDRA News | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
ENDRA Life Sciences (NDRA) Jumps 11% as Momentum Builds Toward Key ResistanceSystematic Flow - newsline.com
NDRA | ENDRA Life Sciences Inc. Insider Trading - Quiver Quantitative
ENDRA Life Sciences (NASDAQ: NDRA) Emerging Diagnostic - openPR.com
NDRA Q1 2026 Earnings: Wider-than-Expected Loss Amid No RevenueLong-Term Guidance - newsline.com
NDRA Q1 2026 Earnings: EPS Misses Estimates Amid Continued Development Stage OperationsEarnings Volatility Report - newsline.com
ENDRA Life Sciences (NDRA) Gets a Buy from Ascendiant - The Globe and Mail
NDRA Maintained by Ascendiant Capital -- Price Target Lowered to $25 - GuruFocus
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know - Benzinga
ENDRA Life Sciences (NDRA) Holds Steady Near Support as Micro-Cap Biotech Awaits CatalystsDealer Positioning - The Legal Advocate
ENDRA Life Sciences Announces Strategic Private Placement Financing - The Globe and Mail
ENDRA Life Sciences Withdraws Filing for Securities Offering - Moomoo
ENDRA Life Sciences Inc. Announces Private Placement Securities Purchase Agreement and Issuance of Warrants – May 2026 - Minichart
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.76%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):